Aldeyra Therapeutics (ALDX) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Aldeyra Therapeutics (ALDX) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | 29.47% |
| 10 | Aldeyra Therapeutics | 95.30 Mn | 95.30 Mn | - | -128.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.17% |
| Dec 31, 2025 | 18.40% |
| Sep 30, 2025 | 27.00% |
| Jun 30, 2025 | 8.31% |
| Mar 31, 2025 | 44.54% |
| Dec 31, 2024 | -22.82% |
| Sep 30, 2024 | -19.28% |
| Jun 30, 2024 | -281.02% |
| Mar 31, 2024 | -245.83% |
| Dec 31, 2023 | 31.13% |
| Sep 30, 2023 | -12.58% |
| Jun 30, 2023 | 48.08% |
| Mar 31, 2023 | 66.27% |
| Dec 31, 2022 | 6.73% |
| Sep 30, 2022 | 33.15% |
| Jun 30, 2022 | -35.52% |
| Mar 31, 2022 | -69.74% |
| Dec 31, 2021 | 77.86% |
| Sep 30, 2021 | -47.07% |
| Jun 30, 2021 | 19.80% |